Sayson, Khimberlie .
HRN: 26-18-59 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
11/09/2024
METRONIDAZOLE 5MG/ML, 100ML (VIAL)
11/09/2024
11/10/2024
IVT
500mg
Q8
Thickly Msaf
Waiting Final Action
Indication: Prophylaxis Type of Infection: Prophylaxis Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes